• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SOD2 C47T 多态性影响非酒精性脂肪性肝病纤维化严重程度:来自病例对照和家系内等位基因关联研究的证据。

The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies.

机构信息

Institute of Cellular Medicine, Newcastle University Medical School, Newcastle upon Tyne, UK.

出版信息

J Hepatol. 2012 Feb;56(2):448-54. doi: 10.1016/j.jhep.2011.05.029. Epub 2011 Jul 12.

DOI:10.1016/j.jhep.2011.05.029
PMID:21756849
Abstract

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is a complex disease trait where genetic variations and environment interact to determine disease progression. The association of PNPLA3 with advanced disease has been consistently demonstrated but many other modifier genes remain unidentified. In NAFLD, increased fatty acid oxidation produces high levels of reactive oxygen species. Manganese-dependent superoxide dismutase (MnSOD), encoded by the SOD2 gene, plays an important role in protecting cells from oxidative stress. A common non-synonymous polymorphism in SOD2 (C47T; rs4880) is associated with decreased MnSOD mitochondrial targeting and activity making it a good candidate modifier of NAFLD severity.

METHODS

The relevance of the SOD2 C47T polymorphism to fibrotic NAFLD was assessed by two complementary approaches: we sought preferential transmission of alleles from parents to affected children in 71 family trios and adopted a case-control approach to compare genotype frequencies in a cohort of 502 European NAFLD patients.

RESULTS

In the family study, 55 families were informative. The T allele was transmitted on 47/76 (62%) possible occasions whereas the C allele was transmitted on only 29/76 (38%) occasions, p=0.038. In the case control study, the presence of advanced fibrosis (stage>1) increased with the number of T alleles, p=0.008 for trend. Multivariate analysis showed susceptibility to advanced fibrotic disease was determined by SOD2 genotype (OR 1.56 (95% CI 1.09-2.25), p=0.014), PNPLA3 genotype (p=0.041), type 2 diabetes mellitus (p=0.009) and histological severity of NASH (p=2.0×10(-16)).

CONCLUSIONS

Carriage of the SOD2 C47T polymorphism is associated with more advanced fibrosis in NASH.

摘要

背景与目的

非酒精性脂肪性肝病(NAFLD)是一种复杂的疾病特征,其中遗传变异和环境相互作用决定疾病的进展。PNPLA3 与进展期疾病的关联已得到一致证实,但许多其他修饰基因仍未被识别。在 NAFLD 中,脂肪酸氧化增加会产生高水平的活性氧。锰依赖性超氧化物歧化酶(MnSOD),由 SOD2 基因编码,在保护细胞免受氧化应激方面发挥重要作用。SOD2 中的一个常见非同义多态性(C47T;rs4880)与 MnSOD 线粒体靶向和活性降低有关,使其成为 NAFLD 严重程度的良好修饰候选基因。

方法

通过两种互补方法评估 SOD2 C47T 多态性与纤维化性 NAFLD 的相关性:我们在 71 个家族三胞胎中寻求父母向患病子女的等位基因优先传递,并在 502 例欧洲 NAFLD 患者的队列中采用病例对照方法比较基因型频率。

结果

在家族研究中,55 个家庭是信息丰富的。T 等位基因在 76 个可能的情况下有 47/76(62%)的传递,而 C 等位基因只有 29/76(38%)的传递,p=0.038。在病例对照研究中,随着 T 等位基因数量的增加,晚期纤维化(分期>1)的存在增加,p=0.008 呈趋势。多变量分析显示,易患晚期纤维化疾病的决定因素是 SOD2 基因型(OR 1.56(95% CI 1.09-2.25),p=0.014)、PNPLA3 基因型(p=0.041)、2 型糖尿病(p=0.009)和 NASH 的组织学严重程度(p=2.0×10(-16))。

结论

携带 SOD2 C47T 多态性与 NASH 中的更晚期纤维化有关。

相似文献

1
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies.SOD2 C47T 多态性影响非酒精性脂肪性肝病纤维化严重程度:来自病例对照和家系内等位基因关联研究的证据。
J Hepatol. 2012 Feb;56(2):448-54. doi: 10.1016/j.jhep.2011.05.029. Epub 2011 Jul 12.
2
The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.载脂蛋白 C3(APOC3)T-455C 和 C-482T 启动子区域多态性与非酒精性脂肪性肝病患者的肝损伤严重程度无关,而与 PNPLA3 I148M 基因型有关。
J Hepatol. 2011 Dec;55(6):1409-14. doi: 10.1016/j.jhep.2011.03.035. Epub 2011 Jul 21.
3
[Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease].PNPLA3基因中的rs738409多态性与非酒精性脂肪性肝病的遗传易感性相关
Zhonghua Gan Zang Bing Za Zhi. 2013 Aug;21(8):619-23. doi: 10.3760/cma.j.issn.1007-3418.2013.08.013.
4
A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease.一项多民族研究探讨了 PNPLA3 基因变异及其与非酒精性脂肪性肝病疾病严重程度的关系。
Hum Genet. 2012 Jul;131(7):1145-52. doi: 10.1007/s00439-012-1141-y. Epub 2012 Jan 19.
5
Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis.非酒精性脂肪性肝炎中微粒体甘油三酯转运蛋白基因和锰超氧化物歧化酶基因的多态性
J Hepatol. 2004 May;40(5):781-6. doi: 10.1016/j.jhep.2004.01.028.
6
Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study.联合遗传变异以提高非酒精性脂肪性肝病及其向肝硬化进展的风险预测:概念验证研究。
Can J Gastroenterol Hepatol. 2018 Mar 14;2018:7564835. doi: 10.1155/2018/7564835. eCollection 2018.
7
The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.载脂蛋白基因 PNPLA3 I148M 多态性与血糖正常人群的胰岛素抵抗和非酒精性脂肪性肝病相关。
Liver Int. 2011 Oct;31(9):1326-31. doi: 10.1111/j.1478-3231.2011.02526.x. Epub 2011 Apr 5.
8
The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study.非酒精性脂肪性肝病与基因多态性的关联:一项多中心研究。
Eur J Gastroenterol Hepatol. 2017 Apr;29(4):441-447. doi: 10.1097/MEG.0000000000000813.
9
A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children.载脂蛋白基因中的一个常见变异是台湾肥胖儿童非酒精性脂肪肝的一个危险因素。
J Pediatr. 2011 May;158(5):740-4. doi: 10.1016/j.jpeds.2010.11.016. Epub 2010 Dec 18.
10
I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.I148M 伴血小板型磷酸脂酶结构域包含 3 基因变异与儿科非酒精性脂肪性肝病严重程度的关系。
Hepatology. 2010 Oct;52(4):1274-80. doi: 10.1002/hep.23823.

引用本文的文献

1
Serum manganese and its association with non-alcoholic fatty liver disease: findings from NHANES.血清锰及其与非酒精性脂肪性肝病的关联:美国国家健康与营养检查调查结果
Front Nutr. 2025 Mar 28;12:1527207. doi: 10.3389/fnut.2025.1527207. eCollection 2025.
2
A 4-year cohort study of the effects of PNPLA3 rs738409 genotypes on liver fat and fibrosis and gut microbiota in a non-fatty liver population.一项针对非脂肪肝人群的PNPLA3 rs738409基因型对肝脏脂肪、纤维化及肠道微生物群影响的4年队列研究。
Environ Health Prev Med. 2025;30:17. doi: 10.1265/ehpm.24-00365.
3
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis.
代谢功能障碍相关脂肪性肝炎的当前治疗现状
Int J Mol Sci. 2025 Feb 19;26(4):1778. doi: 10.3390/ijms26041778.
4
Macronutrient Modulation in Metabolic Dysfunction-Associated Steatotic Liver Disease-the Molecular Role of Fatty Acids compared with Sugars in Human Metabolism and Disease Progression.代谢功能障碍相关脂肪性肝病中的常量营养素调节——脂肪酸与糖类在人体代谢和疾病进展中的分子作用比较
Adv Nutr. 2025 Mar;16(3):100375. doi: 10.1016/j.advnut.2025.100375. Epub 2025 Jan 20.
5
An epidemiological study on the factors including genetic polymorphism influencing ALT >30 U/L and liver fibrosis progression in metabolic dysfunction-associated steatotic liver disease among the general population.一项关于普通人群中代谢功能障碍相关脂肪性肝病中影响谷丙转氨酶(ALT)>30 U/L及肝纤维化进展的因素(包括基因多态性)的流行病学研究。
JGH Open. 2024 Dec 19;8(12):e70043. doi: 10.1002/jgh3.70043. eCollection 2024 Dec.
6
Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review.代谢功能障碍相关脂肪性肝病引起的抗氧化系统变化:综述
Arch Toxicol. 2025 Jan;99(1):1-22. doi: 10.1007/s00204-024-03889-x. Epub 2024 Oct 23.
7
Investigating the Relationship Between Rare Genetic Variants and Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease.探究儿童非酒精性脂肪性肝病中罕见基因变异与纤维化之间的关系。
medRxiv. 2024 Mar 4:2024.03.02.24303632. doi: 10.1101/2024.03.02.24303632.
8
Influence of Cytokine Genetic Polymorphisms in -Associated Gastric Inflammation According to Sex in South Korea.韩国人群中细胞因子遗传多态性与胃炎症相关的性别差异。
Gut Liver. 2024 Nov 15;18(6):1002-1013. doi: 10.5009/gnl230359. Epub 2024 Feb 23.
9
Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD).代谢相关脂肪性肝病(MAFLD)中的线粒体功能障碍。
Int J Mol Sci. 2023 Dec 15;24(24):17514. doi: 10.3390/ijms242417514.
10
Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity.线粒体和 NOX4 依赖性抗氧化防御减轻肥胖导致的非酒精性脂肪性肝炎进展。
J Clin Invest. 2023 Dec 7;134(3):e162533. doi: 10.1172/JCI162533.